MONIMUS CAPITAL MANAGEMENT, LP
Position in VKTX — Viking Therapeutics, Inc.
CIK 1848831
WOODBRIDGE, NJ
Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,207,546
+$1,805,017 QoQ
Shares Held
67,841
+492.9% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MONIMUS CAPITAL MANAGEMENT, LP holds $16,649,678 across 10 Biotechnology names. VKTX ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRTA |
Prothena Corp Public Ltd Co
|
485,617 | $4,720,197 | |
| 2 | ARDX |
Ardelyx, Inc.
|
443,775 | $2,658,212 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
This page
|
67,841 | $2,207,546 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
19,114 | $1,858,836 | |
| 5 | ASMB |
Assembly Biosciences, Inc.
|
48,390 | $1,342,822 | |
| 6 | PEPG |
PepGen Inc.
|
598,663 | $1,059,633 | |
| 7 | QTTB |
Q32 Bio Inc.
|
134,310 | $862,270 | |
| 8 | TECX |
Tectonic Therapeutic, Inc.
|
26,753 | $826,935 |
All Filings in VKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,207,546 | 67,841 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $402,529 | 11,442 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $787,795 | 29,977 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $623,598 | 23,532 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $546,828 | 22,643 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $845,281 | 21,006 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||